ea0065p290 | Neuroendocrinology | SFEBES2019
Lynch Julie
, Kyriakakis Nikolaos
, Elliott Mark
, Baldwin Lisa
, James Anneli
, Seejore Khyatisha
, Ghosh Dipansu
, Nix Mitchell
, Watts Sue
, Sathyapalan Thozhukat
, Murray Robert D
Introduction: The prevalence of acromegaly in the general population ranges 4−14/100 000. 45−80% of acromegaly patients have obstructive sleep apnoea (OSA). The OSA population might represent a target group for earlier detection of acromegaly, thereby reducing associated long-term morbidity.Methods: Patients attending the sleep service (11/2014−04/2018) were recruited in a prospective multicentre cohort study. All had serum IGF-1 measur...